Background: Anecdotal information suggests that clinical practice regarding the use of putative hepatoprotective agents in TB treatment varies across countries in the WHO European Region.
Methods: Between November 2023 and May 2024, we conducted a standardised questionnaire survey on the use of putative hepatoprotective agents in patients receiving TB treatment among Tuberculosis Network European Trials Group (TBnet) representatives in countries in the WHO European Region.
Results: We received valid responses from 37 of 53 countries (69.
PHENIX presents a simultaneous measurement of the production of direct γ and π^{0} in d+Au collisions at sqrt[s_{NN}]=200 GeV over a p_{T} range of 7.5 to 18 GeV/c for different event samples selected by event activity, i.e.
View Article and Find Full Text PDFBackground: This study aimed to identify factors that influence the mortality rate of patients with coronavirus disease (COVID-19)-associated pulmonary aspergillosis (CAPA).
Methods: In this cross-sectional study, data from 23 centers across 15 countries, spanning the period of March 2020 to December 2021, were retrospectively collected. The study population comprised patients who developed invasive pulmonary aspergillosis while being treated for COVID-19 in the intensive care unit.